These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial.
    Author: Snijders D, Schoorl M, Schoorl M, Bartels PC, van der Werf TS, Boersma WG.
    Journal: Eur J Intern Med; 2012 Jul; 23(5):436-41. PubMed ID: 22726372.
    Abstract:
    BACKGROUND: D-dimer levels are in several studies elevated in patients with CAP. In this study we assess the use of D-dimer levels and its association with severity assessment and clinical outcome in patients hospitalised with community-acquired pneumonia. METHODS: In a subset of randomised trial patients with community-acquired pneumonia serial D-dimer levels was analysed. CURB-65 scores were calculated at admission. RESULTS: A total of 147 patients were included. D-dimer levels at admission were higher in patients with severe CAP (2166 ± 1258 versus 1630 ± 1197 μg/l, p=0.03), with clinical failure at day 30 (2228 ± 1512 versus 1594 ± 1078 μg/l, p=0.02) and with early failure (2499 ± 1817 μg/l versus 1669 ± 1121 μg/l, p=0.01). Non-survivors had higher D-dimer levels (3025 ± 2105 versus 1680 ± 1128 μg/l, p=0.05). None of the 16 patients with D-dimer levels<500 μg/l died. In multivariate analysis D-dimer levels were not associated with clinical outcome. D-dimer levels have poor accuracy for predicting clinical outcome at day 30 (AUC 0.62, 95% CI 0.51-0.73) or 30 day mortality (AUC 0.71 (95% CI 0.51-0.91)). Addition of D-dimer levels to CURB-65 did not increase accuracy. No differences were observed in serial D-dimer levels between patients with clinical success or failure at day 30. CONCLUSION: D-dimer levels are elevated in patients with CAP. Significantly higher D-dimer levels are found in patients with clinical failure and with severe CAP. D-dimer levels as single biomarker or as addition to the CURB-65 have no added value for predicting clinical outcome or mortality. D-dimer levels<500 μg/l may identify candidates at low risk for complications.
    [Abstract] [Full Text] [Related] [New Search]